TITLE:
      Selegiline in Outpatient Treatment for Cocaine Dependence - 1
SUMMARY:
      The purpose of this study is to evaluate the efficacy and clinical safety of selegiline in
      the treatment of cocaine dependence and to assess neurotoxicity (Magnetic Resonance Imaging,
      MRI) post-hoc as a possible variable for future stratification in clinical trials.
ELIGIBILITY CRITERIA:
      Inclusion Criteria:

        M/F ages 21-50. Meets DSM-IV critera for cocaine. Agreeable to conditions of study and
        signed informed consent.

        Exclusion Criteria:

        Psychiatric disorder that requires medication therapy. History of seizures. Pregnant
        and/or nuring women. Dependence on ETOH or benzodiazepines or other sedative/hypnotics.
        Acute hepatitis. Other medical condtions that deem participation to be unsafe.
